Public health has become heated, with the fiery debate over e-cigarettes pushing one public health director over boiling point, and public health leaders across Europe becoming incensed by changes at […]
Editors at large
The BMJ Today: Medicines have a new competitor—gamification
Gamification is a theory, not just a trend. It is the use of game mechanics to solve real world problems, and that includes those that originate in the body. If […]
The BMJ Today: You don’t always get what you pay for
On bmj.com today, researchers have found that a much cheaper treatment for wet age related macular degeneration causes no more side effects than the far more expensive licensed treatment. Zosia […]
The BMJ Today: Watch out for the quiet ones
I’m always pleased to see that people keep an eye on changes that are announced quietly by big organisations. Jim Murray alerts us to a discreet switch made by the […]
The BMJ Today: The perils of not keeping your mouth shut
A few weeks ago, I had to take parenteral antibiotics for a condition that was not improving with oral antibiotics. Moreover, in my native Portugal it is still common, for […]
The BMJ Today: Medical device regulation – still out of joint
The introduction of new orthopaedic implants has for some time been a major focus of attention within scientific and policy circles since concerns about certain devices used in total hip […]
The BMJ Today: Read this, but no emailing please
Arterial and venous thromboses are common serious postoperative complications (about 8% of surgical procedures are followed by a thrombosis). The fact that they are still so common despite years of […]
The BMJ Today: Communication of risk – a week of reflection
This week has highlighted for those in healthcare the intricacy of communicating risk to patients and their families. In an emotive blog relating to the case of Ashya King, Tessa […]
The BMJ Today: A story in need of an end
A good story has a beginning, a middle, and an end. A few days ago, we published a sad story in The BMJ Analysis section about the use of beta-blockers […]
The BMJ Today: Bladder cancer—things can only get better
As diseases go, bladder cancer has a pretty raw deal. It lacks the attention and research funding given to other urological cancers (I’m looking at you prostate cancer), and—perhaps most […]